chr1-220618669-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP3BP6

The NM_018650.5(MARK1):​c.823C>T​(p.Arg275Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000205 in 1,460,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

MARK1
NM_018650.5 missense

Scores

8
6
5

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: 5.99
Variant links:
Genes affected
MARK1 (HGNC:6896): (microtubule affinity regulating kinase 1) Enables several functions, including ATP binding activity; phospholipid binding activity; and protein kinase activity. Involved in intracellular signal transduction and protein phosphorylation. Located in cytoplasm; dendrite; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.793
BP6
Variant 1-220618669-C-T is Benign according to our data. Variant chr1-220618669-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2681387.Status of the report is no_assertion_criteria_provided, 0 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MARK1NM_018650.5 linkuse as main transcriptc.823C>T p.Arg275Cys missense_variant 9/18 ENST00000366917.6 NP_061120.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MARK1ENST00000366917.6 linkuse as main transcriptc.823C>T p.Arg275Cys missense_variant 9/181 NM_018650.5 ENSP00000355884 P3Q9P0L2-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1460784
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
726730
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000378

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

EBV-positive nodal T- and NK-cell lymphoma Benign:1
Likely benign, no assertion criteria providedresearchDepartment of Clinical Pathology, School of Medicine, Fujita Health University-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
34
DANN
Uncertain
1.0
DEOGEN2
Benign
0.10
T;.;.;T
Eigen
Uncertain
0.22
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.99
D;D;D;D
M_CAP
Uncertain
0.14
D
MetaRNN
Pathogenic
0.79
D;D;D;D
MetaSVM
Benign
-0.29
T
MutationAssessor
Benign
2.0
.;.;.;M
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Pathogenic
0.94
D
PROVEAN
Pathogenic
-7.5
.;.;D;D
REVEL
Uncertain
0.59
Sift
Uncertain
0.0050
.;.;D;D
Sift4G
Pathogenic
0.0
D;D;D;D
Polyphen
1.0, 1.0, 1.0
.;D;D;D
Vest4
0.73
MutPred
0.59
Loss of MoRF binding (P = 0.0108);Loss of MoRF binding (P = 0.0108);.;Loss of MoRF binding (P = 0.0108);
MVP
0.87
MPC
2.3
ClinPred
0.96
D
GERP RS
4.0
Varity_R
0.88
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1359424178; hg19: chr1-220792011; COSMIC: COSV65066270; API